| | 78919-13-8 Basic information More.. |
| Product Name: | ILOPROST | | Synonyms: | (16r,s)-methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandini(sub2);1h)-pentalenylidene)-;pentanoicacid,5-(hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octen-6-ynyl)-2(;zk36374;6,9ALPHA-METHYLENE-11ALPHA,15S-DIHYDROXY-16-METHYL-PROSTA-5E,13E-DIEN-18-YN-1-OIC ACID;Endoprost;Ilomedin;(5E)-5-[(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-ynyl]-2(1H)-pentalenylidene]pentanoicacid | | CAS: | 78919-13-8 | | MF: | C22H32O4 | | MW: | 360.49 | | EINECS: | | | Mol File: | 78919-13-8.mol |  |
Use
Iloprost is a stable epoprostenol derivative which acts as an inhibitor of platelet
aggregation and is recommended for the treatment of peripheral vascular diseases. The
compound was shown to be a potent agonist at PGE2-sensitive and
prostacyclin-sensitive receptors in animal studies. Iloprost is administered by IV
infusion and has been reported to have beneficial effects in Buerger's and Raynaud's
diseases as well as peripheral artery occlusive disease.
- ILOPROST
-
- US $7.00 / KG
- 2019-07-10
- CAS: 78919-13-8
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100KG
|
|
78919-13-8
Recommend Suppliers |
|